Igyxos

About:

Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.

Website: http://www.igyxos.com/

Top Investors: Bpifrance, GO CAPITAL, Sofimac Innovation

Description:

Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.

Total Funding Amount:

7.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nouzilly, Centre, France

Founded Date:

2017-01-01

Contact Email:

contact(AT)igyxos.com

Founders:

Marie-Christine Maurel

Number of Employees:

1-10

Last Funding Date:

2019-03-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai